Genocea Biosciences, Inc. (NASDAQ:GNCA), a clinical-stage
biopharmaceutical company developing T cell-directed vaccines and
immunotherapies, announced today that it will hold a conference call and
live audio webcast on November 6, 2014 at 9:00 a.m. ET to discuss
financial results for the third quarter ended September 30, 2014.
LAS VEGAS, NV and JAKARTA, INDONESIA --
Schwab Charitable, one of the nation’s leading donor-advised fund
organizations, announced today that it has made over $4.6 billion in
grants on behalf of its donors to more than 86,000 charities since its
inception 15 years ago.
Although emerging markets (EM) stocks have disappointed investors in
recent years, several factors indicate a potential turning point for the
performance of EM stocks, says a new whitepaper by Charles Schwab.
Interthinx, Inc., a subsidiary of First American Financial Corporation
(NYSE: FAF) and a leading provider of comprehensive risk mitigation
solutions for the financial services industry, has been named the
recipient of Mortgage Technology magazine’s 2014 Lasting Impact
Baxter International Inc. (NYSE:BAX) presented the results of a Phase
2/3 study of its investigational 20 percent concentration subcutaneous
immunoglobulin treatment for primary immunodeficiencies (PI) during the
biennial congress of the European Society for Immunodeficiencies, held
NEWPORT BEACH, CA--(Marketwired - October 30, 2014) - Accelerize
(OTCQB: ACLZ) (OTCBB: ACLZ) and its digital marketing software division CAKE , along with Tipalti , a leading global pay-outs management automation platform, today announced their latest innovation, a seamless mass pay-out solution that integrates with real-time digital marketing campaign tracking and attribution analytics.
The Wagner Firm announces that it is investigating potential claims on
behalf of shareholders of Barrett Business Services, Inc. (“BBSI” or the
“Company”) (NASDAQ:BBSI) concerning possible violations of federal
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.